Challenges in using stem cells for cardiac repair.
Of the many diseases discussed in the context of stem cell therapy, those concerning the heart account for almost one-third of the publications in the field. However, the long-term clinical outcomes have been disappointing, in part because of preclinical studies failing to optimize the timing, number, type, and method of cell delivery and to account for shape changes that the heart undergoes during failure. In situations in which cardiomyocytes have been used in cell therapy, their alignment and integration with host tissue have not been realized. Here we review the present status of direct delivery of stem cells or their derivative cardiomyocytes to the heart and the particular challenges each cell type brings, and consider where we should go from here.
Mummery
Christine L
CL
Department of Anatomy and Embryology, Leiden University Medical Centre, 2300 RC Leiden, Netherlands. C.L.Mummery@lumc.nl
Davis
Richard P
RP
Krieger
Jose E
JE
D000818:Animals; D006801:Humans; D023421:Models, Animal; D009206:Myocardium / Q000166:cytology* / Q000473:pathology*; D032383:Myocytes, Cardiac / Q000166:cytology / Q000637:transplantation; D033581:Stem Cell Transplantation; D013234:Stem Cells / Q000166:cytology*; D014945:Wound Healing